Ciprofol group (n = 64) | Propofol group (n = 64) | P-value | |
---|---|---|---|
Age,year,mean ± SDs | 42.2 ± 9.46 | 44.1 ± 9.4 | 0.21 |
Weight,Kg,mean ± SDs | 58.7 ± 6.1 | 59.8 ± 6.9 | 0.37 |
Height,cm,mean ± SDs | 160.6 ± 4.4 | 160.2 ± 4.9 | 0.62 |
BMI,Kg/m2,mean ± SDs | 22.8 ± 2.2 | 23.3 ± 2.6 | 0.21 |
ASA status,n(%) | |||
I | 18(28.1) | 14(21.9) | 0.41 |
II | 46(71.9) | 50(78.1) | |
Operation type,n(%) | |||
Uteroscope | 48(75.0) | 54(84.4) | |
Conization of cervix | 16(25.0) | 9(14.1) | 0.18 |
other | 0(0.0) | 1(1.6) | |
Venipuncture site,n(%) | |||
Back of the hand | 46(71.9) | 33(51.6) | |
Wrist | 15(23.4) | 22(34.4) | 0.059 |
Forearm | 0(0) | 1(1.6) | |
Elbow | 3(4.7) | 8(12.5) | |
Induced dose,mg,mean ± SDs | 29.4 ± 3.0 | 119.5 ± 13.9 | |
Maintenance Dose,mg,mean ± SDs | 14.8 ± 9.8 | 85.6 ± 44.0 | |
Anesthesia time,min,mean ± SDs | 19.4 ± 8.2 | 19.9 ± 6.5 | 0.68 |